Latest News
Haemonetics Corporation
- Recon: AZ, Oracle partner for AI-powered clinical trials; FDA approves Haemonetics vascular closure system
- Haemonetics wins US FDA approval for PerQseal Elite vascular closure device
- FDA Clears Haemonetics PerQseal Elite Vascular Closure System
- Haemonetics says FDA clears vascular closure device
- Haemonetics receives FDA approval for vascular closure device By Investing.com
- Haemonetics announces FDA approval of PerQseal Elite: Will HAE hold $118.33 support?
- Haemonetics Corporation (HAE) Wins FDA Approval for PerQseal Elite
- PepsiCo Beats Estimates; Hallador Wins $700M Contracts; Haemonetics Jumps 17.88%; DarkIris Plunges 60.26% on Financing
- Haemonetics Stock Hits 52-Week High - Here's Why
- Why is Haemonetics stock surging today? By Investing.com
- Haemonetics Stock Surges as Plasma Deal Opens Door to More Revenue
- Haemonetics: Non‑exclusive CSL Plasma supply deal; rollout expected by end‑2027
Headlines from the last 30 days, linking to the original publishers. See all market news →